NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 137 filers reported holding NEKTAR THERAPEUTICS in Q3 2023. The put-call ratio across all filers is 5.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8 | +14.3% | 12,702 | -0.8% | 0.00% | – |
Q2 2023 | $7 | -41.7% | 12,802 | -26.4% | 0.00% | – |
Q1 2023 | $12 | -69.2% | 17,405 | -0.3% | 0.00% | – |
Q4 2022 | $39 | -99.9% | 17,455 | -15.9% | 0.00% | – |
Q3 2022 | $66,000 | -16.5% | 20,754 | -0.2% | 0.00% | – |
Q2 2022 | $79,000 | -37.3% | 20,804 | -11.5% | 0.00% | – |
Q1 2022 | $126,000 | -61.0% | 23,504 | -1.9% | 0.00% | -100.0% |
Q4 2021 | $323,000 | -40.3% | 23,953 | -20.6% | 0.00% | 0.0% |
Q3 2021 | $541,000 | +19.4% | 30,176 | +14.1% | 0.00% | 0.0% |
Q2 2021 | $453,000 | -13.5% | 26,455 | +0.9% | 0.00% | 0.0% |
Q1 2021 | $524,000 | +22.1% | 26,222 | +3.9% | 0.00% | 0.0% |
Q4 2020 | $429,000 | +0.9% | 25,247 | -1.7% | 0.00% | 0.0% |
Q3 2020 | $425,000 | -33.1% | 25,676 | -6.4% | 0.00% | -50.0% |
Q2 2020 | $635,000 | +34.0% | 27,436 | +3.1% | 0.00% | 0.0% |
Q1 2020 | $474,000 | -21.1% | 26,602 | -4.5% | 0.00% | 0.0% |
Q4 2019 | $601,000 | +6.9% | 27,857 | -9.8% | 0.00% | 0.0% |
Q3 2019 | $562,000 | -41.1% | 30,887 | +15.2% | 0.00% | -50.0% |
Q2 2019 | $954,000 | +18.1% | 26,813 | +11.4% | 0.00% | 0.0% |
Q1 2019 | $808,000 | +35.3% | 24,075 | +32.4% | 0.00% | +33.3% |
Q4 2018 | $597,000 | -39.9% | 18,183 | +11.4% | 0.00% | -40.0% |
Q3 2018 | $994,000 | +51.3% | 16,320 | +21.3% | 0.01% | +66.7% |
Q2 2018 | $657,000 | -31.3% | 13,457 | +49.5% | 0.00% | -40.0% |
Q1 2018 | $956,000 | +194.2% | 9,004 | +65.5% | 0.01% | +150.0% |
Q4 2017 | $325,000 | – | 5,440 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Camber Capital Management LP | 2,000,000 | $67,200,000 | 3.35% |
First Light Asset Management, LLC | 763,403 | $25,650,000 | 3.33% |
BRIDGER MANAGEMENT, LLC | 1,238,489 | $41,613,000 | 3.29% |
Rhenman & Partners Asset Management AB | 734,445 | $24,677,000 | 2.89% |
BB BIOTECH AG | 2,020,676 | $67,895,000 | 1.71% |
Gs Investments, Inc. | 54,200 | $1,821,120,000 | 1.43% |
Artal Group S.A. | 900,000 | $30,240,000 | 1.24% |
Cormorant Asset Management, LP | 500,000 | $16,800,000 | 1.14% |
TOBAM | 640,547 | $21,522,000 | 1.09% |
Bellevue Group AG | 430,026 | $14,449,000 | 0.80% |